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Abstract 
Fibronectin fragments damage cartilage in vitro by greatly enhancing metalloproteinases and suppressing proteoglycan (PG) synthesis 
which results in severe cartilage PG depletion. Since reactive oxygen species (ROS) have been implicated in catabolic ytokine action and 
preliminary data suggested that catabolic ytokines uch as TNF-a, IL-1 a, IL-1/3 and IL-6 are responsible for fibronectin fragment 
mediated amage, selected anti-oxidants (AOs) were tested as inhibitors of cytokine, ROS and fibronectin fragment activity. Damage was 
measured by depletion of cartilage PG during tissue culture. The AO, N-acetylcysteine (NAC), decreased the extent of cartilage PG 
depletion caused by TNF-a and IL-I c~ and by the ROS, hydrogen peroxide and superoxide anion, confirming that the cytokines operate 
through ROS and that ROS can initiate cartilage PG depletion. NAC at 0.1 and 1 mM, totally suppressed PG depletion caused by a highly 
potent amino-terminal 29-kDa fibronectin fragment (Fn-f) for 14 days in culture. NAC at l0 mM totally blocked Fn-f mediated PG 
depletion for 21 days and increased the cartilage PG content by 30% above normal evels. Glutathione (10 /zM) and DMSO (1%) were 
also totally effective while catalase and superoxide decreased Fn-f mediated amage only during the first week and superoxide dismutase 
alone caused amage after 1 wk. The AOs caused protection by reducing the major catabolic activities of the Fn-f: enhanced release of 
stromelysin-1 (MMP-3) and suppression of PG and protein synthesis. NAC also decreased normal rates of PG degradation and increased 
the half-lives of labeled PG in both control and Fn-f treated cartilage. We conclude that the Fn-f mediates cartilage chondrolysis through 
ROS, consistent with the involvement of catabolic ytokines in the Fn-f mechanism, and that AOs greatly reduce Fn-f mediated cartilage 
chondrolysis. In an accompanying manuscript we also report hat AOs promote reparative responses in Fn-f and cytokine treated cartilage. 
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1. Introduction 
We earlier discovered that specific proteolytic frag- 
ments of fibronectin have cartilage chondrolytic activities 
[1] and greatly elevate metalloproteinase (MMP) release, 
enhance rates of proteoglycan (PG) loss from cartilage 
tissue in explant cultures [l] and suppress ynthesis of PG 
in cartilage tissue [2]. The fibronectin fragment most active 
toward cartilage tissue, the amino-terminal 29-kDa fi- 
bronectin fragment (Fn-f), has been shown to bind to and 
penetrate intact cartilage to localize around chondrocytes 
Abbreviations: MMP, metalloproteinase; PG, proteoglycan; Fn-f, a 
specific amino-terminal 29-kDa fibronectin fragment; MMP-3, 
stromelysin-1; ROS, reactive oxygen species; AO, anti-oxidant; DMEM, 
Dulbecco's modified Eagle's medium; DMB, dimethylmethylene blue; 
SOD, superoxide ismutase; NAC, N-acetylcysteine 
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[3] in a mode which may involve the fibronectin a 5/31 
receptor since analog peptides of the Arg-Gly-Asp-Ser 
integrin-binding sequence block activities of this Fn-f [4]. 
Stromelysin-1 (MMP-3) appears to he a major MMP in the 
activity [5], although other proteinases may be involved. 
The physiologic significance of these activities is sup- 
ported by our observations that fibronectin fragments of 
29-kDa to 200-kDa can be found at high levels in synovial 
fluids of patients with rheumatoid arthritis and osteoarthri- 
tis [6] and that injection of a mixture of the 29-kDa and 
50-kDa fibronectin fragments into rabbit knee joints causes 
over 50% removal of articular cartilage PG within 7 days 
[7]. Other data suggest hat the potential consequences of
the fibronectin fragments on cartilage tissue pathology in 
vivo could be severe; the damage caused by the Fn-f in 
vitro appears to be irreversible [2,8]. 
The Fn-f exerts its chondrolytic activities by enhancing 
release of the catabolic cytokines, TNF-c~, IL-1 and IL-6, 
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from human cartilage [9]. Neutralizing antibodies to these 
cytokines decrease Fn-f mediated MMP-3 release by up to 
83% and completely reverse PG synthesis uppression [9]. 
Since both IL-1 and TNF-a have been reported to operate 
at least partially through reactive oxygen species (ROS) in 
cartilage [10,11], we have considered that anti-oxidants 
(AOs) may block Fn-f mediated amage as measured by 
cartilage PG depletion of cultured cartilage. We present 
data showing that AOs can reduce catabolic ytokine, ROS 
and Fn-f mediated cartilage chondrolysis. This work also 
suggests the therapeutic potential value of AOs in decreas- 
ing cartilage damage in vivo. In an accompanying 
manuscript we also report that AOs promote reparative 
responses in Fn-f and cytokine treated cartilage. 
2. Materials and methods 
2.1. Materials 
All common chemicals except where noted, were from 
Sigma Chemical Co. (St. Louis, MO). Bovine liver SOD 
(superoxide dismutase) (2500 U/rag protein), catalase, 
N-acetylcysteine, N-acetylalanine, reduced glutathione, te- 
tracycline, butter milk xanthine oxidase (0.42 U/rag) and 
hypoxanthine were from Sigma Chemical Co. [35S]sulfate 
(43 C i /mg S) and [35S]methionine/cysteine (1,000 Ci /ml)  
were from ICN Biomedicals (Cosa Mesa, CA). Recombi- 
nant human TNF-a and IL-I a were from Genzyme Corp. 
(Cambridge, MA). Rabbit anti-sera to human MMP-3 was 
a generous gift from Dr. M. Lark and V. Moore of 
Merck-Sharp and Dohme. 
2.2. Isolation of fibronectin and the Fn-f 
Fibronectin was isolated from human plasma by adsorp- 
tion to gelatin-Sepharose and elution with 3 M urea. The 
amino-terminal heparin-binding 29-kDa Fn-f was isolated 
by sequential cathepsin D and thrombin digests of fi- 
bronectin as described [1]. 
2.3. Explant cartilage cultures 
Culturing of articular cartilage slices from adult (18-20 
mth of age) bovines was performed as described [1-5] in 
DMEM containing 50 U /ml  penicillin/streptomycin with 
10% serum/DMEM with 50-80 mg cartilage in 2 ml of 
media. Each datum was a mean and S.D., based on three 
similar tissue culture wells. Each experiment was per- 
formed with three different cartilage preparations collected 
on separate days with similar observations made in each 
case. Data from a typical cartilage preparation are shown. 
2.4. Assays of PG content of cartilage 
The total amount of PG/mg wet weight cartilage was 
determined by assays with DMB after treatment of 50-80 
mg slices in 1.0 ml of 50 mM phosphate buffer, pH 6, 
containing l0 mM EDTA and l0 mM cysteine, with l 
mg/ml  papain for 8 h at 65°C as originally described [12] 
with minor modifications [2,4]. The data are reported as 
/zg PG/mg wet wt. cartilage based on a mean and S.D. of 
at least three cartilage samples. 
2.5. Rates of [3SS]methionine/cysteine and sodium 
[~SS]sulfate incorporation 
Methionine and cysteine incorporation were used as an 
index of synthesis of general protein and sulfate incorpora- 
tion was used as an index of synthesis of sulfated PG as 
described [2,4]. Cultures were adjusted to 5 #Ci /ml  
[35S]methionine/cysteine or to [35S]sulfate for 2 h and the 
medium then replaced with fresh label free medium for a 2 
h cold chase. The slices in each well were washed several 
times with DMEM and extracted with 2 ml of 4 M GuHCI, 
10 mM EDTA, adjusted to pH 5.5, overnight at 22°C. The 
extracts were then exhaustively dialyzed against 10 mM 
EDTA until the counts in the dialyzate were minimal and 
the extracts then subjected to scintillation counting. The 
mean and S.D. value of the rate was based on 6 similar 
culture wells. The overall variability between similar carti- 
lage culture wells was typically < 12%. 
2.6. Ha!f-life determination of labeled PG 
Bovine articular cartilage was incubated with 20 
/zCi/ml of [35S]sulfate for 72 h, then cold chased for 48 h 
with 10% serum/DMEM. In order to determine the total 
amount of label per mg of cartilage, a few cartilage slices 
were then removed and exposed to 4 M GuHCI, l0 mM 
EDTA, adjusted to pH 5.5, overnight at 22°C to remove 
PG and the extract subjected to scintillation counting. Such 
conditions have been shown by us to remove over 95% of 
the total label. The remaining cultures were then adjusted 
to conditions of with or without 0.1 /zM Fn-f and with or 
without 10 mM NAC. Aliquots of 100 /xl were removed 
periodically to measure release of labeled PG fragments. 
The data were then plotted on a semi-log plot of log of % 
initial label vs time to determine half-lives. 
2.7. Tests of AOs in decreasing Fn-f mediated cartilage 
PG depletion 
Cartilage was allowed to equilibrate in 10% 
serum/DMEM culture for 1 day after dissection. The test 
compound was then added and, within 1 h, the cultures 
were adjusted to 0.1 /xM Fn-f. Separate experiments 
showed that pre-incubation was unnecessary with NAC or 
glutathione, however the data presented for all AOs are 
from pre-incubations. Media were changed every other day 
with test compound added first, followed by addition of 
Fn-f within 1 h. Cartilage was removed at various times 
and subjected to analysis for total PG content. 
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2.8. Tests of effect of superoxide on cartilage PG depletion 
Cartilage was allowed to equilibrate in 10% 
serum/DMEM for 1 day, then the culture was adjusted to 
10 /~g/ml xanthine oxidase and 1 mM hypoxanthine. 
Media were changed every other day with fresh test 
reagents included in each media change. At days 7, 14 and 
21, slices were removed and total PG quantified. In some 
experiments, the cultures were adjusted to various concen- 
trations of AO 1 h before addition of xanthine oxidase and 
hypoxanthine. 
2.9. Western blots 
Electrophoresis and Western blotting of MMP-3 were 
performed as described [5]. Media were concentrated to 
10X, subjected to electrophoresis and blotted onto nitro- 
cellulose. The resultant blots were reacted with a 125-fold 
dilution of rabbit anti-sera to human MMP-3 (final 4 
/xg/ml protein) for 8 h. The blot was washed, reacted 
with125I-labeled protein A and subjected to autoradiog- 
raphy as described [5]. This anti-sera reacts with purified 
human pro-MMP-3 [5], with human pro-MMP-3 activated 
with aminophenylmercuric acid to generate a 43-kDa form 
(unpublished) and with a single 43-kDa protein in 10 to 20 
fold concentrates of both bovine and human cartilage 
conditioned media from 10% serum cultures [5]. These 
43-kDa forms have been shown to be MMPs, with a 
greater specificity toward casein than gelatin ([5]; and 
unpublished). The anti-sera also blocks the cartilage 
degradative properties of the Fn-f [5]. 
3. Results 
3.1. N-acetylcysteine (NAC) reduced the action of TNF-a 
and IL-la on depletion of cartilage PG 
Cartilage chondrolysis by the Fn-f is mediated through 
the action of catabolic cytokines, including TNF-c~ and 
IL-1 a [9]. Since these cytokines generate ROS in chondro- 
cytes [10,11], the AO, NAC, was tested for its effect on 
reducing catabolic cytokine mediated cartilage PG deple- 
tion. Table 1 shows that 1 mM NAC reduced the activities 
of the catabolic cytokines to a significant extent, suggest- 
ing that Fn-f activity should be affected as well. 
3.2. Hydrogen peroxide and a xanthine oxidase /
hypoxanthine superoxide generating system caused carti- 
lage PG depletion but the depletion was suppressed by 
NAC 
In order to implicate hydrogen peroxide as a possible 
agent in causing cartilage damage, cartilage was cultured 
in the presence of 0.1 or 1 mM hydrogen peroxide. Fig. 1A 
shows that both concentrations significantly enhanced PG 
Table 1 
Effect of 1 mM NAC on suppressing PG depletion by TNF-c~ and IL-I ot 
Condition PG P value * * 
content *
Control 100 ± 8 - 
TNF-a 74+6 < 0.0001 
TNF-c~ + 1 mMNAC 94±9 0.13 * * * 
IL-1 c~ 60_+8 < 0.0001 
IL-lo~ + 1 mMNAC 91±12 0.079 *** 
Cartilage in 10% serum/DMEM was adjusted to conditions of 50 U/ml 
IL-lo~ or 10 ng/ml TNF-ot and with or without 1 mM NAC. After 5 
days the PG content was measured and converted into % values in 
relation to the mean of control experiments 
* Means and S.D. values of 6 wells per experiment are shown. S.D. 
values are shown in parentheses. 
* * P values were determined bycomparison tocontrol using the Stu- 
dent's t test. A value of < 0.05 was considered significant. 
* * * Denotes experiments in which NAC was significantly effective. 
depletion, however this activity was totally suppressed by 
the inclusion of 10 mM NAC. Fig. 1B shows that superox- 
ide anion, generated in the presence of xanthine oxidase 
and hypoxanthine, also led to cartilage PG depletion and 
that addition of NAC totally suppressed the activity. 
Therefore, the action of these ROS, which are known to be 
generated through the action of catabolic ytokines, can be 
inhibited by AOs. 
3.3. The AOs, NAC and reduced glutathione, suppressed 
Fn-f mediated PG depletion 
Fig. 2A shows that NAC caused cartilage not incubated 
with Fn-f to increase PG content about 30% above levels 
of control cartilage not incubated with NAC. Fig. 2B 
shows that NAC caused a concentration dependent de- 
crease of the Fn-f mediated PG depletion. A 0.01 mM 
concentration was ineffective, while 0.1 mM protected for 
about 14 days. A 1 mM concentration i creased PG con- 
tent to above control levels during the first 7 days but then 
lost its ability to protect after day 14, as with the 0.1 mM 
concentration. However, 10 mM NAC not only suppressed 
the action of the Fn-f but also increased PG content by 
over 30% above control levels, similar to that observed 
with NAC added to cartilage in the absence of the Fn-f 
(Fig. 2A), and maintained levels above that of control for 
21 days in culture. The protective activity of NAC was due 
to the SH group since an analog, N-acetylalanine, did not 
block PG depletion (data not shown). To demonstrate hat 
NAC did not inactivate the Fn-f directly, a Fn-f solution in 
DMEM was incubated with 10 mM NAC for 3 days at 
37°C followed by dialysis against DMEM. The treated 
Fn-f retained full activity when tested subsequently in 
cartilage chondrolysis. 
Fig. 3A shows that 10 /xM glutathione suppressed Fn-f 
mediated PG depletion for up to 14 days. Control experi- 
ments in which cartilage was incubated with glutathione 
alone did not show a supernormal enhancement of PG 
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content as with NAC.  As a control, the effect of a pre- 
treatment of  the Fn- f  with 10 /xM glutathione was investi- 
gated as described above for NAC and found not to cause 
a significant loss in Fn- f  activity. Fig. 3B shows that 
DMSO totally suppressed PG depletion for up to 21 days. 
Since DMSO does not contain a free SH group and cannot 
reduce disulfides, these data suggest that SH groups are 
not required for a protective ffect and that the ADs do not 
work by disulf ide reduction of  the Fn-f. Tetracycl ine was 
also tested since it has AO properties. A concentration of  
50 I zg /ml  totally suppressed Fn-f  mediated PG depletion 
for 7 days (data not shown); however,  by day 14, the PG 
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Fig. l. Effect of hydrogen peroxide and a xanthine oxidase/hypoxanthine 
superoxide generating system on cartilage PG depletion and of N-acetyl- 
cysteine on decreasing PG depletion. Panel A: Cartilage slices in 10% 
serum/DMEM were incubated with 0.1 or 1 mM hydrogen peroxide and 
with or without 10 mM NAC. Media were changed every other day with 
freshly diluted hydrogen peroxide used in each media change. Tissue was 
analyzed every 7 days for total PG content. Curves shown are control 
cartilage (O); cartilage treated with 0.1 mM hydrogen peroxide continu- 
ously (0); cartilage treated with 1 mM hydrogen peroxide continuously 
(xz); cartilage first adjusted to 10 mM NAC for 1 h followed by 
adjustment to 0.1 mM hydrogen peroxide (• )  or cartilage first adjusted 
to 10 mM NAC for 1 h followed by adjustment to 1 mM hydrogen 
peroxide (El). Panel B: Cartilage was allowed to equilibrate in 10% 
serum/DMEM for 1 day, then the culture was adjusted to 10 p,g/ml 
xanthine oxidase and 2 mM bypoxanthine. Media were changed every 
other day with addition of fresh compounds with each media change. 
Tissue was analyzed every 7 days for total PG content. Curves shown are 
control cartilage (O); cartilage incubated with xanthine oxidase and 
hypoxanthine (0);  and cartilage first adjusted to 10 mM NAC for 1 h, 
followed by addition of xanthine oxidase and hypoxanthine and continu- 
ous treatment ( v ). 
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Fig. 2. Effect of NAC on causing a supernormal PG content in untreated 
control cartilage (A) and in suppressing 0.1 /zM Fn-f mediated PG 
depletion (B). Cartilage cultures were prepared in 10% serum/DMEM 
and incubated with various concentrations of NAC. Media were changed 
every other day and solutions of NAC, prepared within 2 days, were 
added during the change. Tissue was analyzed every 7 days for total PG 
content. PanelA shows the effect of 0.01 (O), 0.1 (v),  1.0 (v )  and 10 
mM (D) NAC on cartilage PG content as compared with untreated 
control cartilage (O). Panel B shows the effect of the same concentra- 
tions of NAC on blocking activity of 0.1 /xM Fn-f. Cartilage was 
adjusted to the same concentrations ofNAC, 0.01 (v), 0.1 (T), 1.0 (O) 
and 10 mM (11) and after 1 h the cultures were then adjusted to 0.1 /zM 
Fn-f. Media were changed every other day with fresh Fn-f and freshly 
prepared NAC included through day 21. An untreated control curve (O) 
and a curve reflecting continuous treatment with 0.1 /xM Fn-f are shown 
(0). In a separate xperiment, 10 mM N-acetylalanine was substituted 
for NAC and added with Fn-f ( z~ ). 
content had decreased to less than that of  the 0.1 /xM Fn-f  
treated cartilage. 
3.4. Catalase and SOD delayed Fn-f mediated cartilage 
PG depletion 
The addition of  SOD which would convert superoxide 
anion to hydrogen peroxide or of  catalase which would act 
on hydrogen peroxide, were tested. Fig. 4 shows that in 
carti lage treated with SOD alone, there was significant PG 
depletion by day 14, l ikely due to generation of  hydrogen 
peroxide. Nonetheless, SOD partially suppressed Fn-f  me- 
diated PG depletion for up to 7 days in culture, but by  day 
14, SOD had totally lost its protective effect. In contrast, 
catalase alone did not cause PG depletion and when added 
with the Fn- f  only al lowed a loss of  PG by day 14: A 
combination of  SOD and catalase was only as effect ive as 
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Fig. 3. Effect of glutathione and DMSO on decreasing Fn-f mediated PG 
depletion. Panel A: Cartilage cultures were prepared in 10% 
serum/DMEM and pre-incubated with 10 IxM glutathione 1 h before 
adjustment of cultures to 0.1 /xM Fn-f. Media were changed every other 
day with addition of a solution of reduced glutathione prepared less than 
4 h earlier. Cartilage PG content was determined atvarious times. Curves 
shown are untreated control cartilage (O); cartilage treated with 0.1 ixM 
Fn-f continuously (0) ;  cartilage treated with 10/,LM glutathione continu- 
ously (v ) ;  cartilage treated first with glutathione followed by adjustment 
to 0.1 p,M Fn+f and continual treatment with both (v) .  Panel B: 
Cartilage cultures were prepared in 10% serum/DMEM and pre-in- 
cubated with 0.1 or 1% DMSO 1 h before adjustment of cultures to 0.1 
/xM Fn-f. Media were changed every other day with fresh Fn-f and 
freshly prepared anti-oxidant included through day 21. Tissue was ana- 
lyzed every 7 days for total PG content. Curves shown are untreated 
control cartilage (O); cartilage treated with 0.1 /xM Fn-f continuously 
(v ) ;  cartilage treated with 0.1% DMSO continuously (~7); cartilage 
treated with 1.0% DMSO continuously (0) ;  cartilage treated first with 
0.1% DMSO (D) or 1% DMSO (11) followed by adjustment to0.1 IxM 
Fn-f and continual treatment with both compounds. 
SOD alone in protecting against Fn-f mediated PG deple- 
tion (data not shown). 
3.5. Allopurinol, a xanthine oxidase inhibitor, suppressed 
Fn-f mediated cartilage PG depletion 
One of the sources of intracellular superoxide anion is 
through the action of xanthine oxidase. The activity of a 
xanthine oxdiase inhibitor, allopurinol, in suppression of 
Fn-f activity was tested. Fig. 5 shows that allopurinol at 50 
p.M effectively suppressed cartilage PG depletion for up to 
7 days in culture. However, the protection was lost by 14 
days. 
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Fig. 4. Effect of catalase and SOD on decreasing Fn-f mediated PG 
depletion. Cartilage cultures were prepared in 10% serum/DMEM and 
pre-incubated with 5 /xg/ml SOD or with 5 /xg/ml catalase or with a 
combination of the same concentrations 1 h before adjustment of cultures 
to 0.1 izM Fn-f. Media were changed every other day with Fn-f and 
enzyme included through day 21. Tissue was analyzed every 7 days for 
total PG content. Curves shown are untreated control cartilage (O); 
cartilage treated with 0.1 /~M Fn-f continuously (0) ;  cartilage treated 
with catalase continuously (n) ;  cartilage treated with catalase for 1 h 
followed by addition of Fn-f and continual treatment with both (11), 
cartilage treated with SOD continuously ( v ); cartilage treated with SOD 
for l h followed by addition of Fn-f and continual treatment with both 
(v ) .  
3.6. NAC decreased the rate of PG release into the media 
of both control and Fn-f treated cartilage 
In order to determine whether the effect of NAC on 
slowing PG depletion was due to enhancing anabolic 
processes or due mainly to blocking catabolic processes, 
the effect of NAC on the kinetics of degradation and 
release of PG into the conditioned media was investigated. 
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Fig. 5. Effect of allopurinol on decreasing Fn-f mediated cartilage PG 
depletion. Cartilage cultures were prepared in 10% serum/DMEM and 
pre-incubated with l0 /xM allopurinol 1 h before adjustment of cultures 
to 0.1 /xM Fn-f. Media were changed every other day. Cartilage PG 
content was determined at various times. Curves shown are untreated 
control cartilage (O); cartilagetreated with 0.1 /xM Fn-f continuously 
(O); cartilage treated first with allopurinol followed by adjustment to 0.1 
/zM Fn-f and continual treatment with both ( v ). 
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Fig. 6 shows data for PG release for that particular day in 
culture and shows that control cartilage not treated with 
Fn-f released PG at constantly increasing rates. Addition of 
the Fn-f caused the rates to increase rapidly to a peak 
period between 6 to 9 days, after which the rates slowly 
declined. However, addition of NAC to the Fn-f treated 
cartilage caused rates to decrease to lower than control 
values. More surprisingly, the NAC added to cartilage not 
treated with Fn-f also decreased rates to lower than control 
values, suggesting that the normal turnover ate of PG has 
been decreased. This effect is consistent with the earlier 
observation that NAC enhanced the total PG content of 
cartilage. 
3.7. NAC increased the half-life of metabolically labeled 
PG 
In order to determine whether NAC has affected the 
rate of turnover of PG, cartilage was first metabolically 
labeled with [ 35 S]sulfate and then cultured with or without 
0.1 /xM Fn-f in the presence or absence of 10 mM NAC in 
10% serum/DMEM. Fig. 7 shows that the control tissue 
had a half-life of about 30 days while addition of Fn-f 
decreased this half-life to about 8 days. This half-life of 8 
days is similar to the time required for about 50% of the 
total PG to be removed from cartilage as shown earlier. 
However, the addition of NAC to untreated or Fn-f treated 
cartilage increased the half-life to about 55 days as shown 
by extrapolation on a separate graph. 
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Fig. 6. Effect of NAC on the rate of PG release into the media of both 
control and Fn-f treated cartilage. Bovine articular cartilage was incu- 
bated with or without 0.1 /zM 29-kDa Fn-f in 10% serum/DMEM in the 
presence orabsence of 10 mM NAC. Aliquots were removed and assayed 
for PG content and the data used to determine /xg PG/mg cartilage/day 
for each respective day. The contents were normalized to reflect a 1 day 
accumulation. Curves hown are untreated control cartilage (©); cartilage 
treated with 0.1 /xM 29-kDa Fn-f continuously (zx); cartilage treated 
with 10 mM NAC alone continuously ([]); cartilage treated with 0. I /xM 
29-kDa Fn-f and 10 mM NAC continuously ( v ). 
sion as measured by suppression of incorporation of 
[35S]sulfate [2,4]. Table 2 shows that while the 0.1 /zM 
Fn-f decreased rates of PG synthesis by about 50%, as we 
have shown elsewhere [2,4,8], inclusion of 10 mM NAC 
significantly reversed this activity. A 1 mM NAC concen- 
tration was less effective than 10 raM, while 0.1 mM was 
3.8. The AOs decreased Fn-f mediated PG depletion partly 
by greatly reducing release of MMP-3 
The effect of the AOs on suppressing release of MMP-3 
was investigated by Western blot analysis of conditioned 
media. The cultures were established in DMEM without 
serum in order to avoid the deleterious effect on elec- 
trophoresis of high concentrations of serum proteins in the 
media concentrates. The serum-free conditions were con- 
sidered appropriate since PG loss also occurs in serum-free 
conditions [1] but with a rate several fold higher than in 
10% serum [5]; PG synthesis uppression occurs to the 
same extent in both conditions [2]; and MMP-3 levels are 
enhanced by over 10-fold in both conditions [1,5]. Fig. 8 
shows that while MMP-3 was almost undetectable in 
control cultures, addition of the Fn-f greatly enhanced the 
intensity of the MMP-3 band. However, addition of NAC, 
glutathione, DMSO or allopurinol to cultures, followed by 
addition of the the Fn-f, greatly reduced MMP-3 protein 
release. 
3.9. The AOs decreased Fn-f mediated PG depletion partly 
by reL, ersing PG synthesis uppression 
AOs were tested for their abilities to reverse another 
major catabolic activity of the Fn-f, PG synthesis uppres- 
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Fig. 7. Effect of NAC on the half-life of metabolically abeled PG. 
Bovine articular cartilage was incubated with 20 /xCi/ml of 35S-sulfate 
for 72 h, then cold chased for 48 h with 10% serum/DMEM. The 
cultures were then incubated with or without 0.1 p-M 29-kDa Fn-f in 
10% serum/DMEM in the presence orabsence of 10 mM NAC. Aliquots 
of i00 /xl were removed periodically tomeasure lease of labeled PG 
fragments. Some aliquots were first dialyzed to ensure that he release 
was of macromolecular sulfate and not free sulfate, The data were then 
plotted on a semi-log plot of log of remaining label vs time to determine 
half-lives. The dotted line corresponds to 50% of the initial abeled PG. 
Curves hown are untreated control cartilage (C)); cartilage treated with 
0.1 /xM 29-kDa Fn-f continuously (r-l); cartilage treated with 10 mM 
NAC alone continuously ( ~7 ); cartilage treated with 0.1 /zM 29-kDa Fn-f 
and 10 mM NAC continuously (zx). 
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Fig. 8. Effect of AOs on MMP-3 release as probed by Western blot 
analysis. Cartilage cultures were prepared in DMEM and incubated with 
AOs, followed after 1 h by adjustment of cultures to 0.1 /zM Fn-f. After 
3 days, the media were recovered, ialyzed against 10 mM NaC1, 10 mM 
Tris, pH 7.4, and concentrated 10X on a Speed Vac concentrator. 
Concentrates were diluted with one volume of Laemmli denaturation 
buffer, reduced with 0.1 M dithiothreitol and aliquots were run on a 10% 
acrylamide SDS gel. The aliquots represented the same weight of carti- 
lage in the original culture. Western blotting was performed as described 
[5] and the blot reacted with anti-sera to human pro-MMP-3, followed by 
reaction with 125I-protein G. Lanes shown are lane 1 (S); molecular 
weight standards of carbonic anhydrase (30-kDa), ovalbumin (43-kDa), 
bovine serum albumin (68-kDa), and phosphorylase a (98-kDa); lane 2 
(C), media from cartilage not treated with the Fn-f; lane 3 (F), media 
from Fn-f treatment; lane 4 (+N), media from pre-incubation with 10 
mM NAC, followed by Fn-f treatment; lane 5 (+G), media from 
pre-incubation with 10 /.tM glutathione followed by Fn-f treatment; lane 
6 (+D), media from pre-incubation with 1% DMSO followed by Fn-f 
treatment; and lane 7 (+A),  media from pre-incubation with 50 /zM 
allopurinol followed by Fn-f treatment. 
Table 2 
Effect of AOs on reversing 0.1 /xM Fn-f mediated suppression of sulfate 
incorporation 
Condition % of P value * * 
control rate * 
Fn-f 52 :k 5 < 0.0001 
1.0 mM NAC 102+9 0.4 
Fn-f + 0.1 mM NAC 53__+ 1 < 0.0001 
Fn-f + 1.0 mM NAC 88 5:12 0.04 
Fn-f + 10 mMNAC 935:11 0.12 * * * 
Fn-f + 1 mM NAA 575-6 < 0.001 
10/zM glutathione 98 5:11 0.37 
Fn-f + 10/.*M glutathione 100+_8 0.5 * * * 
1% DMSO 103+ 13 0.33 
Fn-f + DMSO 95_+7 0.15 * * * 
catalase 91 5- 8 0.05 
Fn-f + catalase 805- 11 0.003 
SOD 77 :k 13 0.003 
Fn-f + SOD 42+_ 11 < 0.0001 
Fn-f + catalase/SOD 69 5:1 < 0.0001 
Cartilage in 10% serum/DMEM was adjusted to conditions indicated, 
followed by adjustment to 0.1 /zM Fn-f. Incorporation i to tissue was 
quantified 24 h later. 
* Mean and S.D. values of 6 wells per experiment are shown. S.D. 
values a/'e shown in parentheses. Means were converted into % values in 
relation to means for control experiments. % values for S.D. values are % 
of means of control. Control cartilage incorporated 1140 _+ 21 dpm/mg 
cartilage. 
* * P values were obtained by comparing experimental means to the 
control mean by a one-sided Student's t test. A value < 0.05 was 
considered significant. 
* * * Denotes experiments in which significant reversal by AOs had 
occurred based on no statistically significant difference with the control 
value. 
inef fect ive .  A 10 mM concent ra t ion  o f  a cont ro l  com-  
pound,  N -acety la lan ine ,  was  inef fect ive ,  suggest ing  the 
impor tance  o f  the SH group  for  the act iv i ty  o f  NAC.  
G lutath ione,  DMSO and cata lase d id  not  alter rates but  
when added wi th  Fn- f ,  s ign i f i cant ly  reversed  the synthes is  
suppress ion  act iv i ty  o f  the Fn- f .  However ,  SOD a lone 
suppressed  PG synthes is  and when added wi th  the Fn - f  
showed no  reversa l  o f  suppress ion .  SOD also b locked  the 
reversa l  e f fec t  o f  cata lase when a combinat ion  o f  the two  
enzymes  was  tested.  
3.10. NAC suppressed Fn-f mediated PG depletion partly 
by reversing eneral protein synthesis uppression 
NAC was  tested for  its abi l i ty to reverse  another  ma jor  
catabo l ic  act iv i ty  o f  the Fn- f ,  suppress ion  o f  synthes is  o f  
genera l  prote in  as measured  by meth ion ine  and cys te ine  
incorporat ion  [2,4]. Tab le  3 shows  that wh i le  the Fn - f  
a lone suppressed  genera l  prote in  synthes is  by  about  50% 
as a lso shown e lsewhere  [2], ad jus tment  o f  Fn - f  t reated 
cu l tures  to 1 or  10 mM NAC s ign i f i cant ly  reversed  genera l  
p ro te in  synthes is  suppress ion .  A concent ra t ion  o f  0.1 mM 
NAC was  inef fect ive .  These  data a lso show that the chon-  
d rocytes  in the presence  o f  the h igher  concent ra t ions  o f  
NAC were  capab le  o f  normal  rates o f  prote in  synthes is  and 
Table 3 
Effect of NAC on reversing 0.1 /zM Fn-f mediated suppression of 
Met/Cys incorporation 
Condition % of P value * * 
Control * 
1 mM NAC 1205:14 0.0073 
0.1 /zM Fn-f 51 +5 < 0.0001 
Fn-f + 0.1 mM NAC 76 + 7 0.002 
Fn- f+ lmMNAC 91+11 0.08 *** 
Fn-f + 10mMNAC 95+9 0.18 * * * 
Cartilage in 10% serum/DMEM was adjusted to 1 mM NAC, 1 h prior 
to adjustment of media to 0.1 p,M Fn-f. Incorporation i to tissue was 
quantified 24 h later 
* Mean are based on n = 6. S.D. values are shown in parentheses. Means 
were converted into % values in relation to means for control experi- 
ments. Control cartilage incorporated 1033 + 79 dpm/mg cartilage. 
* * P values were obtained by comparing experimental means to the 
control mean by a one sided Student's t test. A value < 0.05 was 
considered significant. 
* * * Denotes experiments in which AOs caused significant reversal of 
suppression based on no statistically significant difference with the 
control value. 
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that NAC did not suppress PG depletion simply by slow- 
ing synthesis of degradative proteins. 
4. Discussion 
The ability of AOs to suppress the cartilage PG deple- 
tion activity of IL-I and TNF-a, two catabolic ytokines 
involved in Fn-f mediated amage [9], was tested first in 
order to confirm the involvement of ROS in cytokine 
activity. NAC was tested because of its efficacy in vivo in 
respiratory rheumatologic disorders and in blocking dam- 
age due to chemotherapy drugs (reviewed in Ref. [13]). 
NAC did greatly reduce the PG degradation activity of the 
cytokines as well as that of two mediators which con- 
tribute to cytokine activities, hydrogen peroxide and super- 
oxide anion. NAC also suppressed Fn-f mediated cartilage 
damage as measured by PG depletion, apparently by par- 
tially or totally suppressing three known cartilage chon- 
drolytic activities of the Fn-f, enhanced release of MMP-3 
and suppression of PG and general protein synthesis. Since 
protein synthesis was returned to control levels by NAC, 
we can conclude that the AOs did not slow damage simply 
by decreasing synthesis of degradative proteinases and that 
the AOs were not irreversibly cytotoxic. Another AO, 
reduced glutathione, was also totally effective, while 
DMSO which has been reported to be active in blocking 
TNF-c~ induction of IL-8, a process directly stimulated by 
hydrogen peroxide [14], was less effective. Tetracycline, 
known to have AO properties [15,16] and to scavenge 
hypochlorous acid in patients with rheumatoid arthritis 
[16,17], was tested and found to be effective only for the 
first few days in culture. 
Not only did the highest concentrations of NAC block 
PG depletion, but in some cases, increased the PG content 
of Fn-f treated cartilage to about 30% above normal evels. 
NAC had a similar effect on cartilage not treated with 
Fn-f, suggesting that NAC either enhanced anabolic pro- 
cesses uch as PG synthesis or slowed catabolic processes 
involved in normal tissue turnover. Since NAC was found 
to slow the release of PG fragments and to increase the 
half-life of metabolically abeled PG, the NAC has appar- 
ently slowed normal catabolic processes which may be 
mediated by cytokines. 
The mechanism for the effect of the AOs likely in- 
volves their ability to decrease intracellular levels of hy- 
drogen peroxide, an apparent mediator of cytokine activi- 
ties. Hydrogen peroxide has been suggested to have vari- 
ous signaling activities based on the effect of exogenous 
hydrogen peroxide on various types of cells. For example, 
exogenous hydrogen peroxide has been shown to induce 
heat shock proteins [18], increase c-myc and c-fos mRNA 
levels in vascular smooth muscle cells [19], induce IL-8 
production in Hep-G2 cells, pulmonary epithelial cells and 
human skin fibroblasts [20] and induce diacylglycerol for- 
mation and protein kinase C activation in vascular en- 
dothelial cells [21]. One of the means by which hydrogen 
peroxide may exert some of these effects may be through 
the general ability of ROS to activate NFKB, a transcrip- 
tion factor, which after activation, is translocated to the 
nucleus and activates genes involved in cytokine responses 
(as reviewed [22-24]). Consistent with this possible mech- 
anism, TNF-ce [25] and exogenous ROS [26] have been 
shown to activate NFK B [25] and NAC has been shown to 
block NFKB activities in general [27] as well as the 
specific ability of NFKB activity to mediate IL-1 induced 
secretion of IL-6 [28]. However, other ROS may also be 
active in signal transduction, such as linoleic acid hydro- 
peroxide, which has been shown to induce MMP-3 and 
collagenase just as do catabolic ytokines [29]. 
The NAC may also alter activities of NO, another 
secondary messenger, which is enhanced by IL-I/3 and 
TNF-a [30,31] through induction of nitric oxide synthase 
[32]. Since NO can stimulate guanylate cyclase activity 
[33] and can inhibit receptor tyrosine phosphatase activities 
[34] and ROS can stimulate tyrosine phosphorylation [35], 
the NAC may have suppressed ROS mediated tyrosine 
phosporylation, NO mediated stimulation of guanylate 
cyclase and NO mediated inhibition of tyrosine phos- 
phatase. 
The ROS generated in cytokine treated cells occur in 
part through induction of xanthine oxidase, as shown for 
IL-1 and TNF-o~ [36], which increases uperoxide anion 
and other free radicals [37] and leads to enhanced levels of 
hydrogen peroxide. These cytokines have been shown to 
increase intracellular levels of hydrogen peroxide in chon- 
drocytes [10,11]. IL-1, IL-6 and TNF-c~ have also been 
shown to induce the Mn-SOD gene [20,38-42] which 
would ultimately lead to high levels of hydrogen peroxide. 
In order to determine whether inactivation of ROS was 
the means by which the AOs reduced Fn-f activities, we 
tested the effects of catalase and SOD and found that 
catalase was the most effective. Since catalase should have 
decreased levels of hydrogen peroxide in the conditioned 
media and SOD should have had the opposite ffect, these 
data are consistent with a role for hydrogen peroxide in 
stimulating cartilage chondrolysis. Allopurinol, a xanthine 
oxidase inhibitor, also effectively decreased cartilage PG 
depletion, presumably by inhibiting a major source of 
superoxide anion and an indirect source of hydrogen per- 
oxide. 
In summary, these data show that AOs can totally or 
partially block catabolic ytokine, ROS and Fn-f mediated 
cartilage chondrolysis, consistent with the involvement of 
ROS in catabolic cytokine action and of catabolic cy- 
tokines and ROS in the Fn-f mechanism. Since cytokines 
contribute to the progression of cartilage pathology, such 
as observed in rheumatoid arthritis or osteoarthritis, AOs 
may have potential in facilitating cartilage repair. In an 
accompanying manuscript we also report that AOs pro- 
mote reparative responses in Fn-f and cytokine treated 
cartilage. 
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